biotech

Adrenomedullin, New Drug Target for Treating Lymphedema

Filed in archive Drugs, Vaccines and Therapeutics on December 27, 2007

Adrenomedullin, New Drug Target for Treating Lymphedema
Researchers have identified a hormone that plays a role in cardiovascular disease and other cell functions which may also be a drug target to treat lymphedema, a condition that causes painful swelling in arms and legs.
By increasing adrenomedullin within the cells of the lymphatic system, the researchers believe that they can encourage the lymph sacs to proliferate and take up more fluid. Not only could this approach provide a new treatment for lymphedema, but it may also prove useful in preventing the spread of cancer because invasive cancers sometimes penetrate the lymphatic vessels and metastasize to distant sites.

"In cancer treatments of the future, patients suffering from these aggressive cancers could be identified early and could be treated with a drug to inhibit the growth of the lymph vessels that transport the cancerous cells, thus keeping the cancer in check," Caron said.

The study has been published recently in the Journal of Clinical Investigation.

Image Credit: VascularWeb.org


Permalink: Adrenomedullin, New Drug Target for Treating Lymphedema

Tags: lymphedema  drug+discovery  cancer  cardiovascular+disease  drug  drug+target  treating+lymphedema  adrenom 

Vote for Adrenomedullin, New Drug Target for Treating Lymphedema:

  • Currently 9.40/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.40 out of 10 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells